Last $102.87 USD
Change Today -0.96 / -0.92%
Volume 5.8M
GILD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Xetra
As of 2:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew Cheng M.D., Ph.D.

Executive Vice President of HIV Therapeutics and Development Operations, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background*

Dr. Andrew Cheng, MD, PhD has been an Executive Vice President of HIV Therapeutics and Development Operations at Gilead Sciences Inc. since January 28, 2015. Dr. Cheng served as Senior Vice President of HIV Therapeutics at Gilead Sciences, Inc. until January 28, 2015. Dr. Cheng has been Senior Vice President of Development Operations at Gilead Sciences Inc., since January 2009. Dr. Cheng is responsible for Gilead's biometrics, clinical operations, drug safety and public ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

2013-Present
Director

Education*

PhD
Columbia University
MD
Columbia University
Unknown/Other Education
University of California-Los Angeles
Bachelor's Degree
Johns Hopkins University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $102.90 USD -0.93

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Sanofi
€700.0K
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.